tirzepatide adolescent Journal Club Efficacy and safety of tirzepatide
Description
MTC: medullary thyroid carcinoma
Please contact your doctor if you have any questions or concerns regarding your health
The FDA does not conduct premarket review for compounded drugs to evaluate their safety, effectiveness, or quality
A study conducted by the InfantRisk Center (currently under review) found that tirzepatide was either undetectable or barely detectable in breast milk at doses up to 5 mg
